Literature DB >> 1806451

Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.

E Bottini1, F I Pareti, D Mari, P M Mannucci, M L Muggiasca, M Conti.   

Abstract

The follicle ruptures at the time of ovulation and fills with blood, forming a corpus hemorrhagicum. Minor bleeding from the follicle into the abdominal cavity may cause peritoneal irritation and, when it occurs in a patient with a defect of primary hemostasis, hemoperitoneum can occur. Von Willebrand disease and afibrinogenemia are two important bleeding disorders in which both primary hemostasis and coagulation are involved. Bleeding during ovulation is one major clinical complication in women with these disease. We have studied three patients with this hemorrhagic complication. Our data show that oral contraceptives are an effective way to avoid hemoperitoneum.

Entities:  

Keywords:  Biology; Chromosome Abnormalities; Contraception; Contraceptive Methods--beneficial effects; Developed Countries; Diseases; Europe; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Hemic System--complications; Italy; Laboratory Examinations And Diagnoses; Mediterranean Countries; Neonatal Diseases And Abnormalities; Oral Contraceptives--beneficial effects; Ovarian Effects; Ovary; Ovulation; Physiology; Reproduction; Southern Europe; Treatment; Urogenital System

Mesh:

Substances:

Year:  1991        PMID: 1806451

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  7 in total

1.  Massive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia.

Authors:  Jong-Hyun Kim; So-Young Jeong; Dong-Hyu Cho
Journal:  Obstet Gynecol Sci       Date:  2015-09-22

2.  Management of peritoneal hemorrhage due to follicle rupture under anticoagulation therapy.

Authors:  U Ulrich; W G Rossmanith
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

3.  Recurrent massive haemoperitoneum associated with ruptured corpus luteum in women with congenital afibrinogenemia; case report.

Authors:  Özhan Özdemir; Mustafa Erkan Sarı; Aslıhan Kurt; Ertuğrul Şen; Cemal Reşat Atalay
Journal:  Turk J Obstet Gynecol       Date:  2014-12-15

4.  Deletion of RhoA in Progesterone Receptor-Expressing Cells Leads to Luteal Insufficiency and Infertility in Female Mice.

Authors:  Ahmed E El Zowalaty; Rong Li; Yi Zheng; John P Lydon; Francesco J DeMayo; Xiaoqin Ye
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 5.  Hemorrhagic corpus luteum: Clinical management update.

Authors:  Mykhailo V Medvediev; Antonio Malvasi; Sarah Gustapane; Andrea Tinelli
Journal:  Turk J Obstet Gynecol       Date:  2020-12-10

Review 6.  Corpus luteum hemorrhage with acquired hemophilia A: a case report and literature review.

Authors:  Xiaofei Xie; Shaoru Jiang
Journal:  BMC Womens Health       Date:  2022-10-11       Impact factor: 2.742

Review 7.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.